Dr Ian Godsland is Wynn Reader in Human Metabolism at Imperial College London. He is undertaking long-term investigations into metabolic risk factors for diabetes and cardiovascular disease in the context of a range of studies, in particular a cohort study in which intensive metabolic investigations were carried out for 29 years. His main focus is on the measurement and definition of insulin resistance, insulin secretion and the metabolic syndrome, and their roles in type 2 diabetes and coronary heart disease. He also has an extensive background in metabolic risk factor changes associated with use of gonadal steroids,especially oral contraceptive and postmenopausal hormone replacement therapies.
et al., 2021, Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures, Diabetes Obesity & Metabolism, ISSN:1462-8902
et al., 2021, Cross-sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population, Diabetic Medicine, ISSN:0742-3071
et al., 2021, Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom, Plos One, Vol:16, ISSN:1932-6203
et al., 2021, Increased mortality risk in patients with primary and secondary adrenal insufficiency, Journal of Clinical Endocrinology and Metabolism, Vol:106, ISSN:0021-972X, Pages:e2759-e2768
et al., 2021, Increasing glycaemia is associated with a significant decline in HDL cholesterol in women with prediabetes in two national populations, Scientific Reports, Vol:11, ISSN:2045-2322